Efficacy and Safety of Teneligliptin 40  mg in Type 2 Diabetes: A Pooled Analysis of Two Phase III Clinical Studies

ConclusionIncreasing the dosage of teneligliptin from 20 to 40  mg/day has potential as a well-tolerated and effective option for treating type 2 diabetes.FundingMitsubishi Tanabe Pharma Corporation.

Source: Diabetes Therapy - February 12, 2018 Category: Endocrinology Source Type: research